The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 31, 2017
Filed:
Oct. 13, 2014
Applicant:
Sentiss Pharma Private Limited, New Delhi, IN;
Inventors:
Assignee:
Sentiss Pharma Private Limited, New Delhi, IN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/382 (2006.01); A61K 31/535 (2006.01); A61K 31/5377 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 47/38 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/26 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0048 (2013.01); A61K 9/08 (2013.01); A61K 31/382 (2013.01); A61K 31/535 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); A61K 47/38 (2013.01);
Abstract
The present invention relates to a process for manufacturing an ophthalmic formulation of a carbonic anhydrase inhibitor, hydroxyl ethyl cellulose (HEC), and a beta-adrenergic antagonist for use in the treatment of ocular hypertension and glaucoma wherein the ophthalmic pharmaceutical formulation is devoid of benzalkonium chloride or any other preservatives. The present process for manufacturing is simpler, cost effective process to prepare the pharmaceutical ophthalmic formulation in a single tank, without the use of additional tanks that can be sterile filtered.